Literature DB >> 11588653

Antidepressants in social anxiety disorder.

A E Nardi1.   

Abstract

Social anxiety disorder (SAD) is a marked and persistent fear of doing almost everything in front of people due to concerns about being judge by others. An up-to-date review is needed in order to reach a practical judgement of all psychopharmacological data. Case reports, open and double-blind trials with SAD were described and commented upon from a clinical point of view. The MEDLINE system was searched from 1975 to 2001. The references from the selected papers were also used as a source. MAOIs (fenelzine, tranylcypromine), reversible monoamino oxidase-A inhibitors (moclobemide, brofaromine), SSRIs (paroxetine, sertraline, fluoxetine, fluvoxamine) and some other antidepressants (venlafaxine, nefazodone) have proven effective in several studies with various methodologies. The MAOIs have more serious adverse effects and the SSRIs have the best tolerance. SSRIs are efficacious and the first choice of treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588653     DOI: 10.1590/s0004-282x2001000400032

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Social anxiety disorder has social and economic burden.

Authors:  Antonio E Nardi
Journal:  BMJ       Date:  2003-11-29

2.  Psychological impact of alopecia: alopecia may lead to social anxiety.

Authors:  Antonio E Nardi
Journal:  BMJ       Date:  2005-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.